Today's funders are so conservative they only fund the most obvious ideas. At Experiment, we fund the ideas that they won't fund; the ideas that matter. Since founding, over 47,000 citizens have pledged $9 million dollars supporting 900 scientific projects on the platform. 46% of all projects on Experiment are successfully funded. When the projects are finished, the scientists share the scientific results with their backers as lab notes and peer-reviewed publications. Scientists from Stanford, Harvard, and Yale have chosen to use Experiment instead of writing grants. Bill Gates recognized Experiment by saying "this solution helps close the gap for potentially-promising but unfunded projects."

Futura is the first digital dental laboratory in LATAM. We provide intraoral digital scanners to dentists in exchange for a minimum monthly spend on lab services, enabling a fully digital workflow for crowns, bridges, and other prosthetics. We provide dentists with a platform through which they can manage their patients, cases, and in future payments

Fairway Health is an AI-assistant for health insurers to quickly process patient treatment authorizations. We use LLMs to analyze long (70+ page), messy medical records and determine if a patient is eligible for a treatment.

We are India's fastest medicine delivery service. We deliver medicines in just 30 minutes. We have built highly optimized pharmacy stores and a set of internal tools designed to process prescriptions quickly. We also provide easy-to-integrate APIs and SDK for anyone to start a virtual pharmacy without needing a license, pharmacy, or delivery fleet. Any doctor, teleconsultation app, or EMR provider can start delivering medicines to their patients on WhatsApp or App using our service in the background. We have more than 80 B2B partners, including India's top teleconsultation apps, EMR providers, hospitals, elderly care apps, and insurance providers. We operate 24/7 in Gurgaon, New Delhi, and Moradabad and deliver over 15,000 orders monthly. So far, we have processed more than 250K orders and done thousands of life-saving deliveries. We started in 2020 with the vision to build a centralized health record system for India. We had an AI-powered EMR app for doctors and a SaaS for diagnostic labs to add patients' medical records to Farmako Health ID. We have more than 3M health records added on Farmako. In 2022, the Indian government launched ABHA Health ID and we became one of the first official partners with them. In 2023, we launched quick medicine delivery and decided to move forward with ABHA Health ID for medical records. Now, we are building a safe health assistant inside our medicine delivery app, which will be connected to your Health ID and all your past medical records. Our goal is to make it a super-safe and accurate health assistant for the world, which can eliminate your doctor in the long run for all primary care issues.

FastFarma is the digital pharmacy for latam, that offers best price guaranteed and 30 minute delivery with a full service offering.

We are building the first end-to-end digital viral design platform to protect the world against the coming threat of antimicrobial resistance.

Fella is optimized for busy bigger guys who want a no-nonsense solution to getting healthier. Delilah is built for strong women in their prime who want a sustainable solution to feel their best. We use affordable, effective weight loss medication to solve our customers’ most pressing healthcare need, then aim to remain their core healthcare provider for the rest of their life — expanding to hormonal health, mental health, longevity, and primary care. **We’ve grown >1000x since Aug 2021, >100x since Aug 2022, >10x since Aug 2023**. We’re >$50M ARR. We’ve been cashflow positive for the last 24mo. We’re >10,000 customers with high NPS. Almost all of this has so far been through Fella. Delilah is still very new. We’re a young startup and we’re just getting started. This is still Day 1 and all our work is ahead of us. You can read more about working at Fella & Delilah here: https://www.notion.so/Working-at-Fella-Delilah-14a2ac8575d34d148d009bb410387af4?pvs=21

Cancer is a genetic disease. We know this from decades of human and veterinary cancer research. Precision medicine and targeted therapies are successfully used to treat humans with cancer. At FidoCure®, we bring this approach to the world of veterinary medicine. FidoCure® empowers veterinarians to offer genetic sequencing and targeted therapies to treat dogs with cancer. We are committed to expanding the veterinary oncology toolbox for both diagnostics and therapeutics. Our veterinary partners have treated thousands of dogs over the past 30 years and work closely with the growing FidoCure® network of over 143 clinics and 180 forward-thinking veterinary oncologists throughout the US. Together, we can combat canine cancer!

Our platform is simple: we provide everything providers need to go independent, from scheduling and billing to marketing and client support.

Fitia is an AI meal planning and calorie counter app. Our users receive personalized weight loss or muscle gain plans that adapt based on their data, progress, and preferred foods.

We help hospitals 🏥 hire nurses 🧑🏻‍⚕️ from all around the world 🌏 and with technology make the complexity of immigration and licensing simple.

Float connects SuperNurses to home medication visits - making healthcare safer, easier, and cheaper by moving all the visits that don't need a hospital to the home

Flowly’s mobile app is the VR version of Calm with a focus on reducing chronic pain for 100 million Americans. Flowly subscribers receive a $5 VR headset and Heart Rate sensor that collects a user's biometric data like HR and HRV, and converts it to visualizations in virtual experiences that reduce pain by 46%. Flowly is backed by the National Institutes of Health.

In a nutshell: many diseases are caused by how much your cells squeeze (asthma, fibrosis, others). We discover drugs that control how much cells squeeze, with ease, to treat disease. We use patented bioMEMS technology to turn cell strength (cells' ability to pull/ squeeze) into a quantifiable metric in drug discovery, to help find better drugs for mechanical diseases. We screen 100,000s of drugs against numerous contractile human cell types to comprehensively map human mechanobiology (the "contractome") and identify promising drug development starting points to deliver novel medicines to treat mechanically-driven diseases including asthma, hypertension, preterm labor, fibrosis, and others.

Forever Labs collects and stores adult stem cells, and develops therapies based upon stem cell rejuvenation.

Fortuna is a one-stop solution that helps consumers navigate Medicaid end-to-end from eligibility and enrollment to renewing coverage. Our platform creates value as the middleware layer for the $800B Medicaid ecosystem.

AI is transforming healthcare, but the biggest bottleneck remains—procuring and annotating medical images with speed, accuracy, and scale. Frekil eliminates this roadblock. Frekil helps healthcare AI teams, medical device companies, and pharmaceutical companies procure and annotate medical images like X-rays, CTs, MRIs, etc., efficiently for AI training, clinical trials, and FDA approvals. Our AI-assisted platform speeds up annotation 10x while maintaining high accuracy through real-time quality control, consensus checks, and advanced 3D visualization. We also provide tools to track annotator performance, build custom workflows, and increase labeling accuracy. By combining efficiency with precision, Frekil enables teams to build high-quality datasets much faster, supporting the development and deployment of reliable medical AI and clinical research solutions.

AI-powered intake, eligibility and benefits verification for US healthcare providers to radically improve the patient billing experience. If you know senior execs in medical groups or partners in healthcare PE please do connect us. We won’t waste their time: +1 628 468 3232.

Future Fields has developed the world's first multicellular advanced biomanufacturing platform for the production of the most challenging recombinant proteins. We help companies in biotech, life sciences, and pharma by manufacturing their proteins.

FutureClinic is a platform that makes it easy for any doctor to open their own digital clinic. Our AI assistant takes a comprehensive medical history using an empathic chat or voice-based interface, uses sophisticated medical reasoning to narrow down likely diagnoses, and produces evidence-based treatment suggestions for each patient. Licensed doctors then review the text-based summaries of the cases our AI provides, and choose how to manage the patients. In this fashion, we're able to deliver end-to-end healthcare in a way that makes personalized, expert healthcare scalable to 8 billion people around the world.

GEn1E Lifesciences is a Clinical-stage, multi-target company with a unique AI platform. We develop novel, next-generation, immunomodulatory therapies for rare & inflammatory diseases with no effective treatments. Our team is supercharging the drug development cycle by applying AI to multiple-mechanism-of-action protein targets and their natural platform capabilities—creating novel therapeutics at an unprecedented pace. Our AI platform has enabled us to develop a purpose-built therapy for ARDS to reduce its $20 billion cost on society (just in the USA). GEn1E has built a rich pipeline of 21+ novel and selective immunomodulators and has plans to accelerate 2 additional devastating diseases (beyond their lead indication) to IND in the next 12 months. Our AI platform enables tremendous pace and capital efficiency as demonstrated by our progress in ~2 years with seed capital—a stark contrast to the typical spend of $100M+ and 7+ years exhibited in the pharmaceuticals / biotech industry. With ~90% of rare diseases having no therapeutic treatment at all, GEn1E is taking a giant swing that will hopefully bring life-saving therapies to the lives of patients in need. The team at GEn1E has decades of experience in drug development and machine learning. We graduated from YCombinator and Stanford-StartX in late 2019. We are based in Palo Alto, CA.

Galen is an AI-powered personal healthcare companion. We enable patients to securely connect their medical records from over 800 healthcare institutions across more than 12,000 locations in the United States, United Kingdom, and Canada. We also connect with over 20 popular wearable devices including Apple Watch, Fitbit, and Dexcom, bringing all your medical records and health data into one unified space. We founded Galen because for over four years, Viraj struggled to navigate several conditions related to chronic low back pain. He often found himself waiting weeks for responses from his care team, received little guidance or education about new diagnoses, and was overwhelmed trying to manage overlapping conditions and medications. His experiences are not unique. Our healthcare system is overloaded and fragmented, and often, patients are left to navigate their care on their own. Everyday there are nearly 1 billion health-related Google searches, but the responses to such queries are generic and impersonalized, because the searches lack any insight into a users personal health background. By leveraging your own data and state-of-the art LLM memory capabilities, Galen delivers personalized insights, proactive health recommendations, and 24/7 on-demand medical support — empowering patients to be an active part of their health team. We are a consumer app in beta testing and will be available on the App Store soon!